Xingrui Pharma

星锐医药

Xingrui Pharma

Biotech/Healthcare

Founded in August 2021, Xingrui Pharma is committed to developing innovative RNA-based therapeutics to address unmet clinical needs, with a mission to advance human health. Its pipeline spans infectious disease vaccines, cancer immunotherapy, metabolic diseases, and other areas.

Latest round: Series B Extension (2026)

Source: ChinaBulls — chinabulls.com

Last updated 2026-05-01